Bruce F. Kimler - Concepedia

Author

Bruce F. Kimler

University of Kansas Medical Center ORCID

Also Known As

B F Kimler, B Kimler, B. F. KIMLER, B. F. Kimler, B. Kimler, B.F Kimler, B.F. Kimler, BRUCE F. KIMLER, Bruce F Kimler, Bruce F. Kimler

414

Publications

6.4K

Citations

H-Index

209

Concepts

All Affiliations

University of Kansas Medical Center The University of Kansas Cancer Center University of Kansas University Medical Center

About

Bruce F. Kimler is an author at University of Kansas Medical Center specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	84	3K
2	Health Sciences	15	26	691
3	Public Health	8	8	269
4	Management	1	1	18
5	Nursing	1	1	51

Bruce F. Kimler

135

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Short-Term Breast Cancer Prediction by Random Periareolar Fine-Needle Aspiration Cytology and the Gail Risk Model C. J. Fabian, Bruce F. Kimler, C. M. Zalles, JNCI Journal of the National Cancer Institute	2000	274
Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing Priyanka Sharma, Jennifer R. Klemp, Bruce F. Kimler, Breast Cancer Research and Treatment Breast OncologyOncologyMedicineGynecologyPathology	2014	206
Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer Qamar J. Khan, Pavan S. Reddy, Bruce F. Kimler, Breast Cancer Research and Treatment Breast OncologyMedicineBreast CancerAdjuvant Letrozole TreatmentVitamin D Supplementation	2009	184
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz, Clinical Cancer Research	2016	137
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz, Clinical Cancer Research	2018	125
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP) Priyanka Sharma, Bruce F. Kimler, Anne O’Dea, Clinical Cancer Research	2020	105
A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers. Carol J. Fabian, Bruce F. Kimler, Deborah A Brady, PubMed	2002	97
Radiotherapeutic management of medulloblastoma in a pediatric patient with ataxia telangiectasia Robyn M. Hart, Bruce F. Kimler, Richard G. Evans, International Journal of Radiation OncologyBiologyPhysics PediatricsAtaxia TelangiectasiaRadiotherapeutic ManagementPediatric PatientMedicine	1987	92
l-Ascorbic acid induces apoptosis in acute myeloid leukemia cells via hydrogen peroxide-mediated mechanisms Seyeon Park, Seong‐Su Han, Chan H. Park, The International Journal of Biochemistry & Cell Biology Hematological MalignancyBiochemistryHydrogen Peroxide-mediated MechanismsLipid PeroxidationApoptosis	2004	87
Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer Priyanka Sharma, Vandana G. Abramson, Anne O’Dea, Clinical Cancer Research	2021	82

Page 1